Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage

FASEB J. 2009 Nov;23(11):3790-807. doi: 10.1096/fj.09-132621. Epub 2009 Jul 29.

Abstract

Vitiligo is characterized by a patchy loss of inherited skin color affecting approximately 0.5% of individuals of all races. Despite the absence of the protecting pigment and the overwhelming evidence for hydrogen peroxide (H(2)O(2))-induced oxidative stress in the entire epidermis of these patients, there is neither increased photodamage/skin aging nor a higher incidence for sun-induced nonmelanoma skin cancer. Here we demonstrate for the first time increased DNA damage via 8-oxoguanine in the skin and plasma in association with epidermal up-regulated phosphorylated/acetylated p53 and high levels of the p53 antagonist p76(MDM2). Short-patch base-excision repair via hOgg1, APE1, and polymerasebeta DNA repair is up-regulated. Overexpression of Bcl-2 and low caspase 3 and cytochrome c levels argue against increased apoptosis in this disease. Moreover, we show the presence of high epidermal peroxynitrite (ONOO(-)) levels via nitrotyrosine together with high nitrated p53 levels. We demonstrate by EMSA that nitration of p53 by ONOO(-) (300 x 10(-6) M) abrogates DNA binding, while H(2)O(2)-oxidized p53 (10(-3) M) enhances DNA binding capacity and prevents ONOO(-)-induced abrogation of DNA binding. Taken together, we add a novel reactive oxygen species to the list of oxidative stress inducers in vitiligo. Moreover, we propose up-regulated wild-type p53 together with p76(MDM2) as major players in the control of DNA damage/repair and prevention of photodamage and nonmelanoma skin cancer in vitiligo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis / physiology
  • Ataxia Telangiectasia Mutated Proteins
  • Caspase 3 / biosynthesis
  • Cell Cycle Proteins / metabolism
  • Cytochromes c / biosynthesis
  • DNA / metabolism
  • DNA Damage / drug effects*
  • DNA Repair / drug effects
  • DNA-Binding Proteins / metabolism
  • Electrophoretic Mobility Shift Assay
  • Epidermis / drug effects
  • Epidermis / metabolism
  • Guanosine / analogs & derivatives
  • Guanosine / metabolism
  • Humans
  • Hydrogen Peroxide / pharmacology*
  • Middle Aged
  • Oxidation-Reduction
  • Oxidative Stress / drug effects*
  • Peroxynitrous Acid / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-mdm2 / metabolism
  • Tumor Suppressor Protein p53 / metabolism*
  • Tumor Suppressor Proteins / metabolism
  • Up-Regulation
  • Vitiligo / drug therapy*
  • Vitiligo / genetics
  • Vitiligo / metabolism
  • p300-CBP Transcription Factors / metabolism

Substances

  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • Guanosine
  • Peroxynitrous Acid
  • 8-hydroxyguanosine
  • Cytochromes c
  • DNA
  • Hydrogen Peroxide
  • p300-CBP Transcription Factors
  • p300-CBP-associated factor
  • Proto-Oncogene Proteins c-mdm2
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Protein Serine-Threonine Kinases
  • Caspase 3